Integrated Biopharma Valuation
| INBP Stock | USD 0.34 0.01 3.03% |
Integrated Biopharma seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of Integrated Biopharma from evaluating the firm fundamentals such as Current Valuation of 12.05 M, return on equity of 0.13, and Return On Asset of 0.0336 as well as inspecting its technical indicators and probability of bankruptcy. . In general, most investors encourage buying undervalued assets and selling overvalued assets since, at some point, asset prices and their ongoing real values will come together.
Overvalued
Today
Please note that Integrated Biopharma's price fluctuation is out of control at this time. Calculation of the real value of Integrated Biopharma is based on 3 months time horizon. Increasing Integrated Biopharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Integrated otc stock is determined by what a typical buyer is willing to pay for full or partial control of Integrated Biopharma. Since Integrated Biopharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Integrated OTC Stock. However, Integrated Biopharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.34 | Real 0.28 | Hype 0.34 | Naive 0.31 |
The intrinsic value of Integrated Biopharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Integrated Biopharma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Integrated Biopharma helps investors to forecast how Integrated otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Integrated Biopharma more accurately as focusing exclusively on Integrated Biopharma's fundamentals will not take into account other important factors: About Integrated Biopharma Valuation
The otc valuation mechanism determines Integrated Biopharma's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Integrated Biopharma based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Integrated Biopharma. We calculate exposure to Integrated Biopharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Integrated Biopharma's related companies.Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey. Integrated Biopharma operates under Packaged Foods classification in the United States and is traded on OTC Exchange. It employs 147 people.
8 Steps to conduct Integrated Biopharma's Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Integrated Biopharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Integrated Biopharma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Integrated Biopharma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Integrated Biopharma's revenue streams: Identify Integrated Biopharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Integrated Biopharma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Integrated Biopharma's growth potential: Evaluate Integrated Biopharma's management, business model, and growth potential.
- Determine Integrated Biopharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Integrated Biopharma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Integrated Biopharma Growth Indicators
Investing in growth stocks can be very risky. If the company such as Integrated Biopharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 29.9 M | |
| Quarterly Earnings Growth Y O Y | -0.636 | |
| Retained Earnings | -32.3 M |
Additional Tools for Integrated OTC Stock Analysis
When running Integrated Biopharma's price analysis, check to measure Integrated Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Biopharma is operating at the current time. Most of Integrated Biopharma's value examination focuses on studying past and present price action to predict the probability of Integrated Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrated Biopharma's price. Additionally, you may evaluate how the addition of Integrated Biopharma to your portfolios can decrease your overall portfolio volatility.